PATLY.AI
Patent AnalyticsExaminers
Menu
ExaminersSearch
Rankings
InventorsThe most prolific and the fastest-rising inventorsPlacesCities and countries with the most patentsCompaniesEvery company and institution that filesLaw firmsEvery firm and agent that prosecutesExaminer leaderboardsExaminers ranked on every measure
More
TrendsOfficeCompare

Application

17970443 · COMPOUNDS USEFUL IN MODULATING EGFR AND PI3K

Save

Filed 2022-10-20 · Abandoned The official file ↗ · Art unit 1624 · Examiner Kevin Stephen Martin Typical · CPC C07D 401/04 · Mekanistic Therapeutics LLC · Honigman LLP/FZA

Office actions
2
first was Restriction requirement
RCEs
0
no appeal
To first action
8.5 mo
to disposition 26.4 mo
Statutes raised
103 DP
2 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in